FindTrial
Sign In

Clinical trial of the effectiveness and safety of fluorescent imaging system for sentinel lymph node assisted positioning

Clinical trial of the effectiveness and safety of fluorescent imaging system for sentinel lymph node assisted positioning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039542
Enrollment
Unknown
Registered
2020-10-30
Start date
2018-03-01
Completion date
Unknown
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:methylene blue tracer
Index test:indocyanine&#32
green&#32
methylene&#32
blue&#32
tracer

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Primary breast cancer confirmed by core needle biopsy or Mammotome biopsy; 2. No enlarged axillary lymph nodes as verified by palpation, mammography, or breast ultrasound examination; 3. No distant metastasis.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating; 2. Primary breast cancer confirmed by open biopsy; 3. Preoperative radiotherapy at the breast area or neoadjuvant chemotherapy; 4. History of the axillary surgery; 5. Allergy to iodine.

Design outcomes

Primary

MeasureTime frame
Sentinel lymph node location;Number of sentinel lymph nodes;—

Countries

China

Contacts

Public ContactJing Pei

The First Affiliated Hospital of Anhui Medical University

peijing@ahmu.edu.cn+86 13966668272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026